Michel Marre Selected Research

Ramipril (Altace)

7/2016	Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes.
5/2011	Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes.
7/2010	Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes.
9/2008	Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.
4/2008	The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.
11/2007	The CETP TaqIB polymorphism is associated with the risk of sudden death in type 2 diabetic patients.
6/2006	Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
10/2005	Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.
2/2004	Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Marre Research Topics

Disease

100	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2002
32	Vascular Diseases (Vascular Disease) 01/2022 - 04/2009
24	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2001
24	Insulin Resistance 11/2021 - 04/2004
24	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021 - 03/2001
20	Hypertension (High Blood Pressure) 01/2018 - 03/2003
17	Obesity 12/2020 - 04/2004
14	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 03/2003
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2007
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2016 - 04/2004
10	Proteinuria 10/2019 - 03/2001
10	Hyperglycemia 09/2013 - 03/2004
9	Body Weight (Weight, Body) 10/2020 - 08/2002
8	Albuminuria 12/2016 - 03/2003
7	Myocardial Infarction 01/2022 - 04/2008
7	Hypoglycemia (Reactive Hypoglycemia) 09/2018 - 05/2009
6	Chronic Renal Insufficiency 01/2022 - 05/2013
6	Diabetes Complications 10/2021 - 11/2004
6	Diabetes Mellitus 01/2019 - 03/2003
6	Weight Gain 01/2018 - 05/2009
5	Stroke (Strokes) 01/2022 - 07/2012
5	Kidney Diseases (Kidney Disease) 01/2018 - 01/2014
4	Genetic Risk Score 10/2021 - 08/2014
4	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2020 - 11/2004
3	Heart Failure 01/2022 - 11/2010
3	Weight Loss (Weight Reduction) 10/2020 - 05/2013
3	Ischemia 09/2015 - 01/2011
3	Glucose Intolerance 09/2015 - 07/2007
2	Renal Insufficiency (Renal Failure) 01/2022 - 05/2013
2	COVID-19 07/2021 - 01/2021
2	Nausea 10/2020 - 05/2009
2	Diabetic Foot 01/2020 - 01/2016
2	Foot Ulcer 12/2019 - 01/2016
2	Hypotension (Low Blood Pressure) 11/2019 - 01/2017
2	Coronary Disease (Coronary Heart Disease) 12/2018 - 01/2009
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 07/2010
2	Morbid Obesity 04/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

53	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 03/2004
34	Gliclazide (Diamicron)IBA 01/2022 - 06/2008
32	perindopril drug combination indapamideIBA 01/2022 - 04/2009
27	Insulin (Novolin)FDA Link 11/2017 - 04/2006
19	CreatinineIBA 01/2022 - 03/2001
13	AlbuminsIBA 01/2022 - 03/2003
12	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2006
10	LipidsIBA 01/2021 - 08/2002
9	Ramipril (Altace)FDA LinkGeneric 07/2016 - 02/2004
8	AdiponectinIBA 11/2021 - 04/2004
8	Hypoglycemic Agents (Hypoglycemics)IBA 09/2018 - 02/2004
7	Perindopril FDA LinkGeneric 01/2022 - 09/2007
7	Indapamide FDA LinkGeneric 01/2022 - 08/2004
7	HDL CholesterolIBA 01/2021 - 11/2006
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 02/2004
6	Vasopressins (Vasopressin)IBA 01/2018 - 03/2003
5	Biological ProductsIBA 07/2021 - 02/2008
5	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 08/2002
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2020 - 06/2008
5	EnzymesIBA 10/2015 - 04/2007
5	Proteins (Proteins, Gene)FDA Link 06/2010 - 07/2007
4	Advanced Oxidation Protein Products (AOPP)IBA 02/2016 - 01/2014
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2007 - 03/2001
3	AdrenomedullinIBA 01/2022 - 09/2015
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 11/2009
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 06/2007
3	CholesterolIBA 01/2021 - 07/2007
3	Liraglutide FDA Link 10/2020 - 05/2009
3	8-Hydroxy-2'-DeoxyguanosineIBA 01/2020 - 01/2018
3	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 08/2004
3	Peptides (Polypeptides)IBA 12/2018 - 04/2004
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 08/2008
3	omega-Chloroacetophenone (Mace)IBA 01/2018 - 07/2016
3	Superoxide DismutaseIBA 01/2015 - 12/2011
3	Insulin Glargine (Lantus)FDA Link 07/2014 - 04/2012
3	KininsIBA 05/2014 - 08/2009
3	Transcription Factors (Transcription Factor)IBA 02/2009 - 08/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2004 - 02/2002
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 09/2016
2	DiureticsIBA 01/2019 - 08/2004
2	pro-brain natriuretic peptide (1-76)IBA 12/2018 - 08/2014
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2018 - 08/2014
2	Vasodilator Agents (Vasodilators)IBA 12/2018 - 09/2015
2	H-cadherin (T-cadherin)IBA 12/2017 - 12/2017
2	Retinaldehyde (Retinal)IBA 10/2016 - 01/2016
2	glimepiride (Amarel)FDA LinkGeneric 04/2016 - 05/2009
2	IsoprostanesIBA 02/2016 - 01/2015
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2016 - 10/2015
2	KynurenineIBA 01/2016 - 10/2015
2	CytokinesIBA 10/2015 - 02/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015 - 12/2011
2	Kallikreins (Kallikrein)IBA 05/2014 - 08/2009
2	Tissue Kallikreins (Tissue Kallikrein)IBA 05/2014 - 08/2009
2	C-Reactive ProteinIBA 03/2014 - 11/2008
2	Fibrinogen (Factor I)FDA Link 03/2014 - 06/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 04/2011
2	insulin degludecIBA 12/2013 - 04/2012

Therapy/Procedure

18	Therapeutics 01/2021 - 08/2004
9	Surgical Amputation (Amputations) 01/2022 - 01/2015
7	Glycemic Control 06/2020 - 06/2008
5	Kidney Transplantation 01/2019 - 07/2012
2	Orthotic Devices (Orthosis) 01/2020 - 01/2016
2	Light Coagulation 10/2016 - 01/2016